Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell Growth

Journal of Biological Chemistry - United States
doi 10.1074/jbc.c600277200
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Alox5 Blockade Eradicates JAK2V617F -Induced Polycythemia Vera in Mice

Cancer Research
Cancer ResearchOncology
2016English

Ropeginterferon Alpha-2b Targets JAK2V617F-positive Polycythemia Vera Cells in Vitro and in Vivo

Blood Cancer Journal
OncologyHematology
2018English

Polycythemia Vera

Journal of Clinical Investigation
Medicine
1980English

Polycythemia Vera (PV)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2010English

Practice Patterns in the Diagnosis and Treatment of Polycythemia Vera in the Post–JAK2V617F Discovery Era

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2016English

Intracellular Growth Factors in Polycythemia Vera and Other Myeloproliferative Disorders.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1987English

Clonal Analyses Reveal Associations of JAK2V617F Homozygosity With Hematologic Features, Age and Gender in Polycythemia Vera and Essential Thrombocythemia

Haematologica
Hematology
2013English

Erythropoietin Receptors in Polycythemia Vera.

Journal of Clinical Investigation
Medicine
1989English

Polycythemia Vera Terminating in Refractory Ascites

Kitakanto Medical Journal
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy